Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203 is a research paper published in Leukemia (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: CA180819
NCI NIH HHS
Grant: U10 CA180888
NCI NIH HHS
Grant: U10 CA180819
NCI NIH HHS
Grant: UG1 CA233328
National Institutes of Health
Grant: 3U10CA180888-03S1
SWOG Network Group Operations Center of the NCTN
National Institutes of Health
Grant: 2U10CA180819-06
SWOG Statistics and Data Management Center
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
Keywords
Sustainable Development Goals